InvestorsHub Logo
Followers 20
Posts 1631
Boards Moderated 0
Alias Born 11/10/2010

Re: DewDiligence post# 477

Thursday, 07/14/2016 3:23:53 PM

Thursday, July 14, 2016 3:23:53 PM

Post# of 592
Thanks for the color. I should have just provided the analyst quote I am in question to. Here it is.

Evercore ISI analyst Umer Raffat said the market is under-estimating what the Angiomax decision means for Medicines Co. (NASDAQ: MDCO).

"There are 2 issues in a patent litigation: validity and infringement. Today's ruling appears to clear up the case for validity. Infringement inquiry needs to happen (along with some additional proceedings on on-sale bar)," he commented.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EGRX News